184 related articles for article (PubMed ID: 35499264)
1. Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Musall BC; Adrada BE; Candelaria RP; Mohamed RMM; Abdelhafez AH; Son JB; Sun J; Santiago L; Whitman GJ; Moseley TW; Scoggins ME; Mahmoud HS; White JB; Hwang KP; Elshafeey NA; Boge M; Zhang S; Litton JK; Valero V; Tripathy D; Thompson AM; Yam C; Wei P; Moulder SL; Pagel MD; Yang WT; Ma J; Rauch GM
J Magn Reson Imaging; 2022 Dec; 56(6):1901-1909. PubMed ID: 35499264
[TBL] [Abstract][Full Text] [Related]
2. Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic Therapy.
Musall BC; Rauch DE; Mohamed RMM; Panthi B; Boge M; Candelaria RP; Chen H; Guirguis MS; Hunt KK; Huo L; Hwang KP; Korkut A; Litton JK; Moseley TW; Pashapoor S; Patel MM; Reed BJ; Scoggins ME; Son JB; Tripathy D; Valero V; Wei P; White JB; Whitman GJ; Xu Z; Yang WT; Yam C; Adrada BE; Ma J
J Magn Reson Imaging; 2024 Jan; ():. PubMed ID: 38294179
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Abdelhafez AH; Musall BC; Adrada BE; Hess K; Son JB; Hwang KP; Candelaria RP; Santiago L; Whitman GJ; Le-Petross HT; Moseley TW; Arribas E; Lane DL; Scoggins ME; Leung JWT; Mahmoud HS; White JB; Ravenberg EE; Litton JK; Valero V; Wei P; Thompson AM; Moulder SL; Pagel MD; Ma J; Yang WT; Rauch GM
Breast Cancer Res Treat; 2021 Jan; 185(1):1-12. PubMed ID: 32920733
[TBL] [Abstract][Full Text] [Related]
4. Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer.
Musall BC; Abdelhafez AH; Adrada BE; Candelaria RP; Mohamed RMM; Boge M; Le-Petross H; Arribas E; Lane DL; Spak DA; Leung JWT; Hwang KP; Son JB; Elshafeey NA; Mahmoud HS; Wei P; Sun J; Zhang S; White JB; Ravenberg EE; Litton JK; Damodaran S; Thompson AM; Moulder SL; Yang WT; Pagel MD; Rauch GM; Ma J
J Magn Reson Imaging; 2021 Jul; 54(1):251-260. PubMed ID: 33586845
[TBL] [Abstract][Full Text] [Related]
5. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
6. A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer.
Hwang KP; Elshafeey NA; Kotrotsou A; Chen H; Son JB; Boge M; Mohamed RM; Abdelhafez AH; Adrada BE; Panthi B; Sun J; Musall BC; Zhang S; Candelaria RP; White JB; Ravenberg EE; Tripathy D; Yam C; Litton JK; Huo L; Thompson AM; Wei P; Yang WT; Pagel MD; Ma J; Rauch GM
Radiol Imaging Cancer; 2023 Jul; 5(4):e230009. PubMed ID: 37505106
[TBL] [Abstract][Full Text] [Related]
7. A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer.
Jimenez JE; Abdelhafez A; Mittendorf EA; Elshafeey N; Yung JP; Litton JK; Adrada BE; Candelaria RP; White J; Thompson AM; Huo L; Wei P; Tripathy D; Valero V; Yam C; Hazle JD; Moulder SL; Yang WT; Rauch GM
Eur J Radiol; 2022 Apr; 149():110220. PubMed ID: 35193025
[TBL] [Abstract][Full Text] [Related]
8. Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer.
Adrada BE; Candelaria R; Moulder S; Thompson A; Wei P; Whitman GJ; Valero V; Litton JK; Santiago L; Scoggins ME; Moseley TW; White JB; Ravenberg EE; Yang WT; Rauch GM
Cancer; 2021 Aug; 127(16):2880-2887. PubMed ID: 33878210
[TBL] [Abstract][Full Text] [Related]
9. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI.
Zhou Z; Adrada BE; Candelaria RP; Elshafeey NA; Boge M; Mohamed RM; Pashapoor S; Sun J; Xu Z; Panthi B; Son JB; Guirguis MS; Patel MM; Whitman GJ; Moseley TW; Scoggins ME; White JB; Litton JK; Valero V; Hunt KK; Tripathy D; Yang W; Wei P; Yam C; Pagel MD; Rauch GM; Ma J
Sci Rep; 2023 Jan; 13(1):1171. PubMed ID: 36670144
[TBL] [Abstract][Full Text] [Related]
10. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
[TBL] [Abstract][Full Text] [Related]
11. Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.
Li W; Newitt DC; Wilmes LJ; Jones EF; Arasu V; Gibbs J; La Yun B; Li E; Partridge SC; Kornak J; ; Esserman LJ; Hylton NM
J Magn Reson Imaging; 2019 Dec; 50(6):1742-1753. PubMed ID: 31026118
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
[TBL] [Abstract][Full Text] [Related]
13. MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Wu C; Jarrett AM; Zhou Z; Elshafeey N; Adrada BE; Candelaria RP; Mohamed RMM; Boge M; Huo L; White JB; Tripathy D; Valero V; Litton JK; Yam C; Son JB; Ma J; Rauch GM; Yankeelov TE
Cancer Res; 2022 Sep; 82(18):3394-3404. PubMed ID: 35914239
[TBL] [Abstract][Full Text] [Related]
14. Diffusion Kurtosis MR Imaging of Invasive Breast Cancer: Correlations With Prognostic Factors and Molecular Subtypes.
Kang HS; Kim JY; Kim JJ; Kim S; Lee NK; Lee JW; Suh HB; Hwangbo L; Son Y; Grimm R
J Magn Reson Imaging; 2022 Jul; 56(1):110-120. PubMed ID: 34792837
[TBL] [Abstract][Full Text] [Related]
15. Muscle-invasive bladder cancer: pretreatment prediction of response to neoadjuvant chemotherapy with diffusion-weighted MR imaging.
Zhang X; Wang Y; Zhang J; Xu X; Zhang L; Zhang M; Xie L; Shou J; Chen Y
Abdom Radiol (NY); 2022 Jun; 47(6):2148-2157. PubMed ID: 35306580
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer.
Panthi B; Mohamed RM; Adrada BE; Boge M; Candelaria RP; Chen H; Hunt KK; Huo L; Hwang KP; Korkut A; Lane DL; Le-Petross HC; Leung JWT; Litton JK; Pashapoor S; Perez F; Son JB; Sun J; Thompson A; Tripathy D; Valero V; Wei P; White J; Xu Z; Yang W; Zhou Z; Yam C; Rauch GM; Ma J
Front Oncol; 2023; 13():1264259. PubMed ID: 37941561
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Effects of Anti-PD-1 Therapy on Triple-Negative Breast Cancer in Mice by Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced Imaging.
Tang WJ; Yao W; Jin Z; Kong QC; Hu WK; Liang YS; Chen LX; Chen SY; Zhang QQ; Wei XH; Xu XD; Guo Y; Jiang XQ
J Magn Reson Imaging; 2022 Dec; 56(6):1912-1923. PubMed ID: 35499275
[TBL] [Abstract][Full Text] [Related]
18. Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs.
Zhou Z; Adrada BE; Candelaria RP; Elshafeey NA; Boge M; Mohamed RM; Pashapoor S; Sun J; Xu Z; Panthi B; Son JB; Guirguis MS; Patel MM; Whitman GJ; Moseley TW; Scoggins ME; White JB; Litton JK; Valero V; Hunt KK; Tripathy D; Yang W; Wei P; Yam C; Pagel MD; Rauch GM; Ma J
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083160
[TBL] [Abstract][Full Text] [Related]
19. Diffusional kurtosis imaging for differentiation of additional suspicious lesions on preoperative breast MRI of patients with known breast cancer.
Park VY; Kim SG; Kim EK; Moon HJ; Yoon JH; Kim MJ
Magn Reson Imaging; 2019 Oct; 62():199-208. PubMed ID: 31323316
[TBL] [Abstract][Full Text] [Related]
20. Characterization of breast masses as benign or malignant at 3.0T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient.
Suo S; Zhang K; Cao M; Suo X; Hua J; Geng X; Chen J; Zhuang Z; Ji X; Lu Q; Wang H; Xu J
J Magn Reson Imaging; 2016 Apr; 43(4):894-902. PubMed ID: 26343918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
